Astrazeneca (AZN)
Britvic (BVIC)
Anglo American (AAL)
Wh Smith (SMWH)
YouGov (YOU)
Mitchells & Butlers (MAB)
Hargreaves Lansdown (HL.)
Diageo (DGE)
Travis Perkins (TPK)
easyJet (EZJ)
I3 Energy (I3E)2 May 2024 10:04
AstraZeneca notes positive trial results for Calquence treatment
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Tuesday broker round-up
Tue, 02nd Apr 2019 12:14
(Sharecast News) - easyJet: Berenberg upgrades to hold with a target price of 1,040p.Arrow Global Group: Berenberg reiterates sell with a target price of 160p.i3 energy: Canaccord reiterates speculative buy with a target price of 190p.YouGov: Berenberg reiterates buy with a target price of 620p.Next Fifteen Communications: Berenberg reiterates buy with a target price of 680p.WH Smith: Peel Hunt reiterates buy with a target price of 2,500p.Anglo Pacific Group: Peel Hunt reiterates buy with a target price of 213p.Mitchells & Butlers: Liberum reiterates hold with a target price of 270p.Anglo American: Deutsche Bank upgrades to buy with a target price of 2,400p.AstraZeneca: UBS downgrades to sell with a target price of 5,400p.Travis Perkins: UBS reiterates neutral with a target price of 1,350p.Diageo: Barclays initiates at overweight with a target price of 3,470p.Hargreaves Lansdown: Citigroup upgrades to neutral.Britvic: Barclays initiates at equal weight with a target price of 960p.
Related Shares
More News
2 May 2024 07:45
AstraZeneca reports positive results from blood cancer drug trial
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
29 Apr 2024 22:52
J&J, Bristol Myers lose challenges to US drug price negotiation program
April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...
29 Apr 2024 10:02
LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
29 Apr 2024 09:13
AstraZeneca makes progress with Truqap and Enhertu cancer treatments
(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...